COPD-associated miR-145-5p is downregulated in early-decline FEV1 trajectories in childhood asthma

Anshul Tiwari1, Jiang Li1, Alvin T Kho2

  • 1Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.

Insights

Reduced levels of miR-145-5p in children with asthma may predict early decline in lung function, a risk factor for developing chronic obstructive pulmonary disease (COPD). This finding highlights miR-145-5p as a potential early biomarker for COPD risk.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Biomarker Discovery

Background:

  • MicroRNAs (miRNAs) are implicated in asthma and chronic obstructive pulmonary disease (COPD).
  • Children with asthma exhibit diverse lung function growth trajectories, including reduced growth (RG) and early decline (ED), with some patterns linked to adverse outcomes like COPD.

Purpose of the Study:

  • To investigate if circulating miRNAs in early childhood asthma can predict long-term lung function growth patterns over 16 years.
  • To identify specific miRNAs associated with detrimental lung function trajectories.

Main Methods:

  • Small RNA sequencing was performed on sera from 492 children (aged 5-12) with mild-to-moderate asthma.
  • Differential expression analysis of miRNAs was conducted comparing distinct lung function growth patterns.
  • In vitro studies assessed the role of identified miRNAs in airway smooth muscle cell growth.

Main Results:

  • Analysis of 448 samples revealed hsa-miR-145-5p as significantly dysregulated (P < 8.01E-05) when comparing normal growth to the most severe group (RGED).
  • This miRNA was downregulated in both early decline (ED) groups (ED and RGED).
  • In vitro experiments confirmed hsa-miR-145-5p's association with airway smooth muscle cell proliferation.

Conclusions:

  • Downregulation of miR-145-5p is associated with early decline lung function patterns in children with asthma, a precursor to COPD.
  • miR-145-5p promotes airway smooth muscle cell proliferation, suggesting a mechanistic link to disease progression.
  • Reduced miR-145-5p expression may serve as a significant risk factor for long-term lung function decline and COPD development.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
979
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
552